3354-lymeaid-230520
Bay Area Lyme Foundation Celebrates Its 10th Anniversary with a Convergence of Scientists, Clinicians, Patients and Celebrity Talent
June 13, 2023 11:00 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, celebrated its 10th anniversary in May at LymeAid®, its...
BALF_logo_2014_white_blue bckgd_vertical.png
Bay Area Lyme Foundation Celebrates Department of Defense CDMRP Tick-borne Disease Awardees
March 23, 2023 11:00 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces that two projects it has previously funded have...
BALF_logo_2014_white_blue bckgd_vertical.png
National Lyme Clinical Trials Network Gains Its First West Coast Center, Thanks to $1M+ Donation from Bay Area Lyme Foundation
March 09, 2023 11:00 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces it has awarded more than $1M to the University of...
BALF_logo_2014_white_blue bckgd_vertical.png
Bay Area Lyme Foundation Researcher Validates New Approach to Overcome Challenges of Lyme Disease Diagnosis in the Lab
February 06, 2023 11:00 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of a laboratory study published in...
tarsus-logo-stacked-color-532x626.png
Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease
December 15, 2022 08:30 ET | Tarsus Pharmaceuticals, Inc
Positive Phase 1b Callisto data shows that TP-05 is well tolerated and safety data supports progression to Phase 2a Phase 2a Carpo trial to evaluate the safety, tolerability, and proof-of-activity of...
Featured Image for Lifestyle Healing Institute
With Expanded Outdoor Features, Lifestyle Healing Institute Integrates Traditional and Holistic Medicine
August 29, 2022 08:04 ET | Lifestyle Healing Institute
NAPLES, Fla., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Lifestyle Healing Institute, a center for complementary and alternative medicine, treats illnesses with data-driven approaches delivered by a medical...
ADPT new logo.jpg
Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease
June 15, 2022 07:30 ET | Adaptive Biotechnologies
SEATTLE, June 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
MIT PR Lyme Disease Tick
RightEye Enters Into Agreement With MIT to Research Ocular Biomarker 'Signature' for Lyme Disease
April 25, 2022 11:15 ET | RightEye LLC
BETHESDA, Md., April 25, 2022 (GLOBE NEWSWIRE) -- RightEye, the world's leading eye-tracking biomarker company, has signed a research collaboration agreement with the Massachusetts Institute of...
Image
Evidence of Manipulated Lyme Disease Diagnostics Presented to Suffolk County, NY Health Commissioner
March 11, 2022 08:00 ET | TruthCures
GREAT RIVER, N.Y., March 11, 2022 (GLOBE NEWSWIRE) -- Nonprofit grassroots organization TruthCures, Inc. held a virtual meeting with Suffolk County, NY Health Commissioner Gregson Pigott, MD, MPH,...
BALF_logo_2014_white_blue bckgd_vertical.png
Bay Area Lyme Foundation Funds $8M in Tick-borne Disease Research During the Pandemic
January 25, 2022 12:17 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced that the organization has raised more than...